# Blue Owl Capital Holdings LP

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1858703. Source: https://holderbook.com/funds/1858703-blue-owl-capital-holdings-lp/

- Reported value: $664.5M
- Positions: 76
- Weight of the ten largest: 78.5%
- Filed: 2026-08-11

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| SPACE EXPLORATION TECHN CORP | [SPCX](https://holderbook.com/stocks/SPCX/) | $239.0M | 1,398,815 | 36.0% | 1 |
| AKTIS ONCOLOGY INC | [AKTS](https://holderbook.com/stocks/AKTS/) | $99.0M | 3,070,219 | 14.9% | 2 |
| CULLINAN THERAPEUTICS INC | [CGEM](https://holderbook.com/stocks/CGEM/) | $28.0M | 1,539,764 | 4.2% | 11 |
| LARIMAR THERAPEUTICS INC | [LRMR](https://holderbook.com/stocks/LRMR/) | $27.9M | 9,163,157 | 4.2% | 11 |
| NUVEEN CHURCHILL DIRECT LEND | [NCDL](https://holderbook.com/stocks/NCDL/) | $26.6M | 2,143,626 | 4.0% | 8 |
| MAPLIGHT THERAPEUTICS INC | [MPLT](https://holderbook.com/stocks/MPLT/) | $26.2M | 729,929 | 3.9% | 3 |
| CAPITAL ONE FINL CORP | [COF](https://holderbook.com/stocks/COF/) | $24.0M | 119,757 | 3.6% | 1 |
| BLUE OWL CAPITAL CORPORATION | [OBDC](https://holderbook.com/stocks/OBDC/) | $22.2M | 2,045,070 | 3.3% | 15 |
| DEEP FISSION INC | [FISN](https://holderbook.com/stocks/FISN/) | $14.7M | 1,333,333 | 2.2% | 1 |
| DELL TECHNOLOGIES INC | [DELL](https://holderbook.com/stocks/DELL/) | $14.2M | 32,961 | 2.1% | 5 |
| HOLLEY INC | [HLLY](https://holderbook.com/stocks/HLLY/) | $11.2M | 4,376,888 | 1.7% | 8 |
| EYEPOINT INC | [EYPT](https://holderbook.com/stocks/EYPT/) | $10.9M | 762,594 | 1.6% | 7 |
| SAGIMET BIOSCIENCES INC | [SGMT](https://holderbook.com/stocks/SGMT/) | $9.7M | 1,260,544 | 1.5% | 11 |
| CORVUS PHARMACEUTICALS INC | [CRVS](https://holderbook.com/stocks/CRVS/) | $9.1M | 608,600 | 1.4% | 2 |
| ARTIVA BIOTHERAPEUTICS INC | [ARTV](https://holderbook.com/stocks/ARTV/) | $8.5M | 874,542 | 1.3% | 1 |
| COMPASS THERAPEUTICS INC | [CMPX](https://holderbook.com/stocks/CMPX/) | $7.9M | 3,624,076 | 1.2% | 11 |
| CONDUENT INC | [CNDT](https://holderbook.com/stocks/CNDT/) | $7.4M | 5,036,595 | 1.1% | 8 |
| RHYTHM PHARMACEUTICALS INC | [RYTM](https://holderbook.com/stocks/RYTM/) | $6.8M | 61,455 | 1.0% | 2 |
| COMPASS PATHWAYS PLC | [CMPS](https://holderbook.com/stocks/CMPS/) | $6.4M | 450,000 | 1.0% | 1 |
| ULTRAGENYX PHARMACEUTICAL IN | [RARE](https://holderbook.com/stocks/RARE/) | $6.1M | 182,638 | 0.9% | 11 |
| PALVELLA THERAPEUTICS INC NE | [PVLA](https://holderbook.com/stocks/PVLA/) | $5.5M | 36,259 | 0.8% | 7 |
| IMAGENEBIO INC | [IMA](https://holderbook.com/stocks/IMA/) | $5.4M | 917,692 | 0.8% | 4 |
| COMPASS PATHWAYS PLC | [CMPS](https://holderbook.com/stocks/CMPS/) | $5.2M | 0 | 0.8% | 2 |
| VIRIDIAN THERAPEUTICS INC | [VRDN](https://holderbook.com/stocks/VRDN/) | $4.8M | 260,000 | 0.7% | 1 |
| IMMIX BIOPHARMA INC | [IMMX](https://holderbook.com/stocks/IMMX/) | $4.5M | 437,552 | 0.7% | 3 |
| ORIC PHARMACEUTICALS INC | [ORIC](https://holderbook.com/stocks/ORIC/) | $4.3M | 400,000 | 0.7% | 3 |
| LENZ THERAPEUTICS INC | [LENZ](https://holderbook.com/stocks/LENZ/) | $4.3M | 756,722 | 0.6% | 3 |
| AQUESTIVE THERAPEUTICS INC | [AQST](https://holderbook.com/stocks/AQST/) | $3.9M | 942,932 | 0.6% | 10 |
| STARWOOD PPTY TR INC | [STWD](https://holderbook.com/stocks/STWD/) | $3.2M | 196,355 | 0.5% | 2 |
| EVOMMUNE INC | [EVMN](https://holderbook.com/stocks/EVMN/) | $2.4M | 180,000 | 0.4% | 2 |
| ELEDON PHARMACEUTICALS INC | [ELDN](https://holderbook.com/stocks/ELDN/) | $2.2M | 566,509 | 0.3% | 7 |
| CABALETTA BIO INC | [CABA](https://holderbook.com/stocks/CABA/) | $2.2M | 714,710 | 0.3% | 1 |
| CHIME FINL INC | [CHYM](https://holderbook.com/stocks/CHYM/) | $1.8M | 89,878 | 0.3% | 1 |
| CONTEXT THERAPEUTICS INC | [CNTX](https://holderbook.com/stocks/CNTX/) | $1.6M | 2,934,015 | 0.2% | 9 |
| WW INTL INC | [WW](https://holderbook.com/stocks/WW/) | $1.3M | 84,399 | 0.2% | 2 |
| MARKER THERAPEUTICS INC | [MRKR](https://holderbook.com/stocks/MRKR/) | $814.7K | 554,250 | 0.1% | 7 |
| ERASCA INC | [ERAS](https://holderbook.com/stocks/ERAS/) | $795.0K | 0 | 0.1% | 1 |
| ADC THERAPEUTICS SA | [ADCT](https://holderbook.com/stocks/ADCT/) | $784.9K | 733,568 | 0.1% | 16 |
| CYBIN INC | [HELP](https://holderbook.com/stocks/HELP/) | $396.0K | 59,911 | 0.1% | 1 |
| FOLD HLDGS INC | [FLD](https://holderbook.com/stocks/FLD/) | $385.5K | 856,632 | 0.1% | 5 |
| NIOCORP DEVS LTD | [NIOBW](https://holderbook.com/stocks/NIOBW/) | $381.0K | 268,280 | 0.1% | 8 |
| ELEDON PHARMACEUTICALS INC | [ELDN](https://holderbook.com/stocks/ELDN/) | $285.0K | 0 | 0.0% | 1 |
| REZOLVE AI PLC | [RZLVW](https://holderbook.com/stocks/RZLVW/) | $214.0K | 235,121 | 0.0% | 8 |
| BRAND ENGAGEMENT NETWORK INC | [BNAIW](https://holderbook.com/stocks/BNAIW/) | $203.5K | 1,453,808 | 0.0% | 8 |
| PIPER SANDLER COMPANIES | [PIPR](https://holderbook.com/stocks/PIPR/) | $175.6K | 2,428 | 0.0% | 2 |
| ENGENE THERAPEUTICS INC | - | $148.2K | 511,177 | 0.0% | 1 |
| LARIMAR THERAPEUTICS INC | [LRMR](https://holderbook.com/stocks/LRMR/) | $145.7K | 0 | 0.0% | 2 |
| CELCUITY INC | [CELC](https://holderbook.com/stocks/CELC/) | $130.7K | 1,249 | 0.0% | 1 |
| COMPASS THERAPEUTICS INC | [CMPX](https://holderbook.com/stocks/CMPX/) | $106.3K | 0 | 0.0% | 2 |
| STABLECOINX INC | - | $102.5K | 250,000 | 0.0% | 1 |
| ENERGY TRANSFER L P | [ET](https://holderbook.com/stocks/ET/) | $101.8K | 5,326 | 0.0% | 2 |
| CARIS LIFE SCIENCES INC | [CAI](https://holderbook.com/stocks/CAI/) | $84.0K | 4,711 | 0.0% | 2 |
| VODAFONE GROUP PLC | [VOD](https://holderbook.com/stocks/VOD/) | $71.0K | 5,371 | 0.0% | 1 |
| DAVE INC | [DAVEW](https://holderbook.com/stocks/DAVEW/) | $68.4K | 28,750 | 0.0% | 8 |
| MURANO GLOBAL INVT PLC | [MRNO](https://holderbook.com/stocks/MRNO/) | $62.9K | 261,875 | 0.0% | 1 |
| ALPHA MODUS HLDGS INC | [AMODW](https://holderbook.com/stocks/AMODW/) | $55.6K | 1,854,665 | 0.0% | 7 |
| ROADZEN INC | [RDZNW](https://holderbook.com/stocks/RDZNW/) | $42.8K | 225,000 | 0.0% | 8 |
| ALPHA MODUS HLDGS INC | - | $42.0K | 9,853 | 0.0% | 1 |
| AEON BIOPHARMA INC | [AEON](https://holderbook.com/stocks/AEON/) | $30.5K | 42,353 | 0.0% | 6 |
| SOUTHLAND HLDGS INC | [SLNDWS](https://holderbook.com/stocks/SLNDWS/) | $25.8K | 860,302 | 0.0% | 8 |
| BLUE GOLD LTD | [BGLWW](https://holderbook.com/stocks/BGLWW/) | $21.0K | 175,000 | 0.0% | 5 |
| SHF HOLDINGS INC | [SHFS](https://holderbook.com/stocks/SHFS/) | $18.2K | 75,897 | 0.0% | 6 |
| BLACKSKY TECHNOLOGY INC | [BKSYWS](https://holderbook.com/stocks/BKSYWS/) | $17.5K | 350,000 | 0.0% | 8 |
| TEVOGEN BIO HLDGS INC | [TVGNW](https://holderbook.com/stocks/TVGNW/) | $12.0K | 200,000 | 0.0% | 8 |
| ZEO ENERGY CORP | [ZEOWW](https://holderbook.com/stocks/ZEOWW/) | $10.0K | 250,000 | 0.0% | 1 |
| LIVEWIRE GROUP INC | [LVWRWS](https://holderbook.com/stocks/LVWRWS/) | $8.0K | 400,000 | 0.0% | 1 |
| NVNI GROUP LIMITED | [NVNIW](https://holderbook.com/stocks/NVNIW/) | $6.0K | 200,000 | 0.0% | 1 |
| KATAPULT HOLDINGS INC | [KPLT](https://holderbook.com/stocks/KPLT/) | $5.4K | 5,421 | 0.0% | 2 |
| CID HOLDCO INC | [DAICW](https://holderbook.com/stocks/DAICW/) | $4.4K | 444,515 | 0.0% | 5 |
| BAIRD MED INVT HLDGS LTD | [BDMDW](https://holderbook.com/stocks/BDMDW/) | $4.0K | 100,000 | 0.0% | 7 |
| PAGAYA TECHNOLOGIES LTD | [PGYWW](https://holderbook.com/stocks/PGYWW/) | $2.4K | 48,661 | 0.0% | 8 |
| STARDUST PWR INC | [SDSTW](https://holderbook.com/stocks/SDSTW/) | $2.2K | 16,666 | 0.0% | 8 |
| LIMINATUS PHARMA INC. | [LIMNW](https://holderbook.com/stocks/LIMNW/) | $2.0K | 50,000 | 0.0% | 5 |
| WALDENCAST PLC | [WALDW](https://holderbook.com/stocks/WALDW/) | $1.7K | 33,333 | 0.0% | 8 |
| XBP GLOBAL HOLDINGS INC | [XBPEW](https://holderbook.com/stocks/XBPEW/) | $1.5K | 24,778 | 0.0% | 8 |
| ASPIRE BIOPHARMA HLDGS INC | [ASBPW](https://holderbook.com/stocks/ASBPW/) | $1.0K | 50,000 | 0.0% | 6 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +7.3% | +14.8% | -7.5% | 96% |
| Q1 2026 | +3.3% | -4.6% | +8.0% | 98% |
| Q4 2025 | +10.1% | +2.4% | +7.8% | 101% |
| Q3 2025 | +24.5% | +7.8% | +16.7% | 99% |
| Q2 2025 | +8.9% | +10.5% | -1.6% | 99% |
| Q1 2025 | -25.3% | -4.6% | -20.7% | 97% |
| Q4 2024 | -9.5% | +2.1% | -11.6% | 100% |
| Q3 2024 | +10.6% | +5.4% | +5.2% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $664.5M | 76 |
| Q1 2026 | $372.2M | 74 |
| Q4 2025 | $324.0M | 78 |
| Q3 2025 | $322.1M | 72 |
| Q2 2025 | $309.9M | 72 |
| Q1 2025 | $310.1M | 73 |
| Q4 2024 | $434.0M | 78 |
| Q3 2024 | $518.4M | 133 |
| Q2 2024 | $359.6M | 41 |
| Q1 2024 | $500.6M | 44 |
| Q4 2023 | $418.3M | 42 |
| Q3 2023 | $129.3M | 15 |